In a filing, Rhythm Pharmaceuticals Inc revealed its Chief Technical Officer Shulman Joseph unloaded Company’s shares for reported $1.12 million on Oct 30 ’25. In the deal valued at $115.24 per share,9,748 shares were sold. As a result of this transaction, Shulman Joseph now holds 8,509 shares worth roughly $0.89 million.
Then, Shulman Joseph sold 2,815 shares, generating $323,750 in total proceeds. Upon selling the shares at $115.01, the Chief Technical Officer now owns 8,509 shares.
Before that, JOSEPH SHULMAN bought 9,748 shares. Rhythm Pharmaceuticals Inc shares valued at $1,110,200 were divested by the Officer at a price of $113.89 per share.
Goldman initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on July 10, 2025; the price target was $97. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. BofA Securities also remained covering RYTM and has increased its forecast on April 07, 2025 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of RYTM
On Tuesday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -7.69% to $104.99. Over the last five days, the stock has lost -7.47%. Rhythm Pharmaceuticals Inc shares have risen nearly 119.97% since the year began. Nevertheless, the stocks have risen 87.55% over the past one year. While a 52-week high of $116.00 was reached on 10/30/25, a 52-week low of $45.90 was recorded on 04/07/25.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 100.51, which if violated will result in even more drops to 96.02. On the upside, there is a resistance level at 111.07. A further resistance level may holdings at 117.14.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-10-15, growing by 0.35 million shares to a total of 5.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 5.22 million shares. There was a rise of 6.34%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 02, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.
